Internal Medicine, Nephrology · Los Angeles, CA
NPI
1326068560
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
3663 W 6th St Ste 307
Los Angeles, CA, 90020
Phone (213) 736-1884
Groups this clinician bills Medicare through
Medicare paid, 2024
$636K
7,412 services
Medicare patients, 2024
695
Average age 79
Drug cost, 2024
$8.3M
39,058 prescriptions
Company payments, 2025
$2,614
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark M Song was code 99213 (office e&m - established), 2,690 times for 635 patients. In total Mark M Song billed 7,412 services in 39 codes, and Medicare paid $636K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 2,690 | 635 | $76.23 | $205K |
| 36415 Venipuncture Blood Collection | Office | 408 | 246 | $8.65 | $3,529 |
| 99497 Care Management/Coordination | Office | 403 | 401 | $92.24 | $37K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 393 | 390 | $104.86 | $41K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 384 | 380 | $111.70 | $43K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 383 | 383 | $22.87 | $8,759 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 367 | 366 | $182.49 | $67K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 348 | 348 | $22.87 | $7,960 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 342 | 342 | $152.16 | $52K |
| 99214 Office E&M - Established | Office | 222 | 220 | $57.44 | $13K |
| 90960 ESRD Related Services (not dialysis) | Office | 191 | 20 | $318.39 | $61K |
| 76641 Ultrasound - Nonspecific | Office | 181 | 181 | $148.19 | $27K |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 166 | 118 | $47.00 | $7,801 |
| 76856 Ultrasound - Abdomen and Pelvis | Office | 152 | 151 | $102.40 | $16K |
| 96372 Injection Administration | Office | 140 | 59 | $12.22 | $1,711 |
By year: 2022 $769K for 10,357 services; 2023 $729K for 9,307 services; 2024 $636K for 7,412 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 408 | 246 | $8.65 | $3,529 |
| 83036 Blood Count | 61 | 43 | $9.52 | $581 |
| 81002 Clinical Chemistry | 50 | 42 | $3.41 | $171 |
| 82962 Clinical Chemistry | 25 | 21 | $3.21 | $80.25 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark M Song prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,138 prescriptions and refills. In total Mark M Song wrote 39,058 Medicare prescriptions that cost $8.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,138 | 7,167 | 768 | $20K |
| Amlodipine Besylate Generic | 1,848 | 4,128 | 434 | $7,381 |
| Metformin Hcl Generic | 1,425 | 3,267 | 329 | $8,997 |
| Vascepa Icosapent Ethyl | 1,243 | 1,716 | 209 | $573K |
| Losartan Potassium Generic | 1,163 | 2,646 | 282 | $7,585 |
| Celecoxib Generic | 1,029 | 2,045 | 341 | $40K |
| Losartan-Hydrochlorothiazide Losartan/Hydrochlorothiazide | 973 | 2,236 | 242 | $9,294 |
| Tamsulosin Hcl Generic | 967 | 2,086 | 226 | $6,854 |
| Omeprazole Generic | 895 | 1,839 | 271 | $6,717 |
| Creon Lipase/Protease/Amylase | 868 | 1,049 | 188 | $1.3M |
| Farxiga Dapagliflozin Propanediol | 825 | 1,234 | 163 | $689K |
| Simvastatin Generic | 739 | 1,679 | 159 | $4,354 |
| Jardiance Empagliflozin | 670 | 1,011 | 132 | $593K |
| Metoprolol Succinate Generic | 663 | 1,369 | 146 | $5,978 |
| Allopurinol Generic | 596 | 1,096 | 117 | $5,099 |
Brand drugs: 9,531 claims; generic drugs: 28,982 claims; opioid claims: 268.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark M Song $2,614 ($2,614 in general payments such as food, travel and fees) from 19 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $457.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $457 |
| AstraZeneca Pharmaceuticals LP AZN | 18 | $417 |
| Amgen Inc. AMGN | 20 | $307 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $291 |
| Gilead Sciences, Inc. GILD | 11 | $255 |
| Novo Nordisk Inc NVO | 10 | $211 |
| Merck Sharp & Dohme LLC MRK | 4 | $108 |
| Lilly USA, LLC LLY | 4 | $103 |
| Corcept Therapeutics CORT | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $81.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.